Technical Officer - Pharmacovigilance, Brazzaville, Congo

General Description of assignment title: Technical Officer - Pharmacovigilance Assignment country: Congo Duty stations: Brazzaville Work location: On UN premises Expected start date: 09/01/2026 Duration: 12 months(with possibility of extension)Long-term benefits and allowances Sustainable Development Goal: 3. Good health and well-being Host entity: WHO Modality: Onsite Type: International Volunteer category: Expert UCoS from Apr2026 Work schedule: Full-time Number of Assignments: 1 Details Mission and objectives: The World Health Organization is a specialized agency of the United Nations Public Health Organization established in 1948. The objective of the World Health Organization shall be the attainment by all peoples of the highest possible level of health. World Health Organization achieves its goals by performing its essential functions: 1. Take a leadership role in key health issues and create partnerships when joint action is needed; 2. Set research priorities and encourage the acquisition, application and dissemination of useful knowledge; 3. Setting standards and criteria and encouraging and monitoring them; 4. Develop ethical and evidence-based policies 5. Provide technical support, be an agent of change and build institutional capacity in a sustainable way; 6. Monitor health status and assess health trends. Context: Under the overall guidance of the Regional Adviser/Team Lead and in close collaboration with WHO headquarters (HQ), and country offices, the Technical Officer (Pharmacovigilance) will support Member States to implement the WHO Resolution on, and to operationalize the global smart pharmacovigilance strategy, including risk-based prioritization, reliance/work-sharing, integration in regulatory systems, and strengthened safety communication. Task description: 1. Facilitate regional uptake of global normative guidance and technical tools for smart pharmacovigilance and support measurement of uptake and impact of the global smart pharmacovigilance (PV) strategy (e.g., prioritized product lists, Adverse Events of Special Interest (AESI ) risk registers, reliance/work‑sharing, VigiBase use, PV maturity progress). 2. Support pharmacovigilance system assessments (e.g., World Health Organization (WHO) Global Benchmarking Tool - GBT) and assist countries in addressing and implementing PV components of Institutional Development Plans (IDPs). 3. Coordinate with WHO Collaborating Centres in the Region. 4. Support regional implementation of WHO-developed PV tools and protocols (e.g., reporting forms: VigiMobile, VigiFlow/VigiLyze, active surveillance protocol, background data on AESI, Risk Management Plan (RMP) assessment templates), particularly for the introduction of prequalified and new medicines/vaccines, and ensure relevant data are shared with WHO Headquarters (HQ ) advisory committees. 5. Provide feedback to WHO Headquarters (HQ ) on the feasibility and contextualization of global PV metrics; coordinate and support pilots in selected countries and scale‑up as it relates to the WHO Africa region. 6. Strengthen regional PV collaboration, including information‑sharing mechanisms, reliance and work‑sharing arrangements, and joint signal reviews with National Regulatory Authorities (NRAs ) and programmes. 7. Support countries in prioritizing risk‑based PV actions and strengthen collaboration of PV within immunization and public health programmes to reduce data silos, align case definitions, investigations, and risk communication. 8. Advocate for the Vaccine Safety Net (VSN) and promote trustworthy communication channels. 9. Represent the Region in Programme for International Drug Monitoring (PIDM ) forums (e.g., annual meeting) and support the organization of regional PIDM activities when hosted by a Member State. 10. Provide technical assistance to countries to detect and act on local signals and convene regional network meetings on priority topics. 11. Support countries to improve reporting and build capacity for causality assessment and data analysis for safety signals and reporting. 12. Advance the use of artificial intelligence (AI ) in pharmacovigilance in the region. 13. Conduct surveys and landscape analysis of the uptake of the Smart Strategy. 14. Provide support in coordinating and engaging relevant technical experts, as required, for the effective implementation of planned PV activities in the region Eligibility criteria Age: 18 - 80 Required experience: 7 years Nationality: Candidate must be a national of a country other than the country of assignment. Assignment requirements Relevant experience: 7 years Languages: English, Level: Fluent, Required French, Level: Working knowledge, Desirable Portuguese, Level: Working knowledge, Desirable Required education level: Master's degree in pharmaceuticals/pharmacology, pharmacoepidemiology, pharmaceutical sciences or a related field. Desirable: Specialized training in pharmacovigilance, regulatory science, epidemiology/biostatistics, data science/AI ethics, or health informatics. Competencies and values: Teamwork Respecting and promoting individual and cultural differences Communication Producing results Ensuring the effective use of resources Skills and experience: Experience Essential: At least five years of relevant experience in pharmacovigilance/regulatory science/medicines or vaccine safety, including experience with signal detection/assessment and safety communication; experience supporting national authorities or programmes in low- and middle-income countries (LMICs). Desirable: Experience with reliance/work-sharing, Good Benchmarking Tool (GBT) benchmarking/Individual Development Plan (IDP) implementation, active surveillance, and interoperability projects; familiarity with Uppsala Monitoring Centre (UMC)/World Health Organization (WHO) tools (VigiFlow, VigiLyze, VigiMobile/MedSafety) and Medical Dictionary for Regulatory Activities (MedDRA)/WHO Drug Dictionary (WHODrug). Skills and knowledge Applied knowledge of pharmacovigilance (PV) methods across the product life cycle; adverse events of special interest (AESI) case definitions; causality assessment; Risk Management Plan (RMP)/Periodic Safety Update Report (PSUR)/Periodic Benefit-Risk Evaluation Report (PBRER) review; benefit-risk assessment. Practical understanding of risk-based prioritization, reliance/work-sharing models, and integration of pharmacovigilance in regulatory and public health systems. Data skills: management, quality assurance, basic analytics/visualization; familiarity with International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E2B(R3) standards and data governance principles. Excellent writing, facilitation, and stakeholder engagement skills; ability to develop guidance, standard operating procedures (SOPs) and training. Area(s) of expertise: Pharmacy and other allied health professions, Public health, immunisation Driving license: - Other information Tags global health health surveillance health systems strengthening international drug monitoring pharmacovigilance Skills Pharmacovigilance Regulatory Science English French Stakeholder Engagement The recruiting organization, WHO - World Health Organization, has not specified a closing date for this vacancy or continues to list jobs after their stated closing date. Because such positions may remain open, they are listed here until removed from the recruiting organization's website. Click the button below to verify its current status. More Information and Application Details